Evaluation status available after sign-in
About the journal
Clinical Epigenetics is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,190 EUR. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1868-7075 · 1868-7083
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,190 EUR
- Articles in DOAJ
- 1143
- Declared review time
- 12 weeks
- Declared peer-review model
- other
- Official website
- https://clinicalepigeneticsjournal.biomedcentral.com/
Index listings
- DOAJ · 2012-09-19
- MEDLINE · 2016-01-01
- PUBMED · 2010-09-01
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,190 EUR
- Declared review time (DOAJ)
- 12 weeks
- Actual review time (measured)
- 135 days received→accepted — computed from PubMed (n=97)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1143
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
2310
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
114
i10-index
1556
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2012-09-19
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 12%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101516977
Classification4
Subjects (DOAJ)
MedicineScience: Biology (General): Genetics
LCC codes
RQH426-470
Subject areas
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Birth, Development, and Health
- Genetic Associations and Epidemiology
- Genomics and Chromatin Dynamics
- Genetic Syndromes and Imprinting
- Genetic Syndromes and Imprinting
Show all subjects (75)
- Genetic Syndromes and Imprinting
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Cancer-related molecular mechanisms research
- Cancer-related gene regulation
- Cancer-related gene regulation
- Cancer Genomics and Diagnostics
- Birth, Development, and Health
- Birth, Development, and Health
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- RNA modifications and cancer
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- Chromatin Remodeling and Cancer
- Acute Myeloid Leukemia Research
- Genetic factors in colorectal cancer
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Health, Environment, Cognitive Aging
- Health, Environment, Cognitive Aging
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Immune cells in cancer
- Immune cells in cancer
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Telomeres, Telomerase, and Senescence
- MicroRNA in disease regulation
- RNA modifications and cancer
- Glioma Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Asthma and respiratory diseases
- Prenatal Screening and Diagnostics
- Prenatal Screening and Diagnostics
- Gut microbiota and health
- Genomic variations and chromosomal abnormalities
- Gut microbiota and health
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Protein Degradation and Inhibitors
- Kruppel-like factors research
- Protein Degradation and Inhibitors
- Kruppel-like factors research
- Cancer Cells and Metastasis
- Head and Neck Cancer Studies
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Smoking Behavior and Cessation
- Genetics, Aging, and Longevity in Model Organisms
- Folate and B Vitamins Research
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Pregnancy and preeclampsia studies
- Pregnancy and preeclampsia studies
- Cancer Immunotherapy and Biomarkers
- Cervical Cancer and HPV Research
Keywords (DOAJ)
- genetic processes
- epigenetic therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ